About 90% of the active ingredients used by US companies in drug manufacturing come from China. That’s been the case for a number of years, but the coronavirus outbreak has put that dependence under scrutiny. Congress is now taking up the issue as pharmacies and hospitals brace for shortages because of disrupted production in China. Marco Werman talks with Rosemary Gibson, author of “China RX: Exposing the Risks of America’s Dependence on China for Medicine.”
There is no paywall on the story you just read because a community of dedicated listeners and readers have contributed to keep the global news you rely on free and accessible for all. Will you join the 319 donors who have supported The World so far? From now until Dec. 31, your gift will help us unlock a $67,000 match. Donate today to double your impact!